Teladoc Health, Inc. (TDOC) is a publicly traded Healthcare sector company. As of October 19, 2026, TDOC trades at $5.70 with a market cap of $1.03B and a P/E ratio of -5.08. TDOC moved +0.26% today. Year to date, TDOC is -19.00%; over the trailing twelve months it is -37.14%. Its 52-week range spans $4.40 to $11.55. Analyst consensus is neutral with an average price target of $7.67. Rallies surfaces TDOC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TDOC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $5.70 |
| Market Cap | $1.03B |
| P/E Ratio | -5.08 |
| EPS | $-1.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.55 |
| 52-Week Low | $4.40 |
| Volume | 425.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.53B |
| Net Income | $-200.32M |
| Gross Margin | 0.00% |
16 analysts cover TDOC: 0 strong buy, 4 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.67.